Technical documentation for laboratory, infection-control, and connected-care procurement
Technical documentation for laboratory, infection-control, and connected-care procurement
Clinical applications
Expand a setting to see the operational evidence, integration boundary, and limitations that shape selection.
Review: 600–2,000 tests/hour requirement bands where relevant, sample loading, reagent stability, calibration interval, coefficient of variation, carryover, LIS routing, and downtime fallback.
Trade-off: Centralized automation can lower cost per test and strengthen QC traceability, while distributed point-of-care testing may shorten clinical decision time. Neither approach is preferable without volume, transport, staffing, and acuity data.
Limits: Throughput maxima may exclude reruns, calibration, maintenance, STAT interruption, and sample-quality exceptions.
Review: limit of detection, reportable range, precision, interference, lot-to-lot behavior, method comparison using Deming regression or Bland–Altman analysis, and traceability of calibrators.
Limits: A method verified for one matrix, concentration range, or population cannot be assumed valid for another. Local verification remains part of laboratory governance.
Review: HL7 message profiles, middleware ownership, identity and role controls, result-release rules, network segmentation, SBOM availability, outage behavior, and change control.
Trade-off: A tightly integrated single-vendor architecture may simplify accountability; a modular architecture may reduce lock-in but adds interface validation and multi-party support boundaries.
Review: sterility assurance level (SAL), ISO 11135 or applicable sterilization evidence, packaging integrity, shelf life, lot traceability, reprocessing validation, cycle records, and waste handling.
Trade-off: Single-use products simplify per-procedure sterility control but increase material waste; validated reusable pathways can reduce waste but require equipment, trained staff, monitoring, and documented reprocessing discipline.
Review: measurement range and accuracy, alarm handling, battery runtime, FHIR or HL7 exchange, data latency, access control, privacy, network loss, and clinical escalation.
Limits: Connectivity does not replace clinical review; wearable fit, motion artifact, home network quality, battery state, and patient adherence can change usable data.
Review: preventive maintenance, mean time to repair, parts horizon, software support, training, consumables, decontamination, cybersecurity response, and decommissioning.
Limits: Service availability, regulatory status, and product configuration vary by market. Contract language and current model documentation govern.